Sionna Therapeutics
(NASDAQ) SION
Sionna Therapeutics Financials at a Glance
Market Cap
$1.60B
Revenue (TTM)
$0.00
Net Income (TTM)
-$85.57M
EPS (TTM)
-$1.92
P/E Ratio
-18.45
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$35.51
Volume
10,803
Open
$38.10
Price
$35.51
Volume
10,803
Open
$38.10
Previous Close
$35.51
Daily Range
$35.29 - $38.10
52-Week Range
$13.51 - $48.45
Estimated Earnings Date
Aug 10, 2026
Dividend
$0.00
Beta (Volatility)
1.04 (Average)
Price
$35.51
Volume
10,803
Open
$38.10
Previous Close
$35.51
Daily Range
$35.29 - $38.10
52-Week Range
$13.51 - $48.45
Estimated Earnings Date
Aug 10, 2026
SION News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sionna Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
59
CEO
Michael Cloonan, MBA
Website
www.sionnatx.comHeadquarters
Waltham, MA 02451, US
SION Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-27%
Return on Capital
-34%
Return on Assets
-28%
Earnings Yield
-5.42%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.60B
Shares Outstanding
45.15M
Volume
10.80K
Avg. Volume
389.08K
Financials (TTM)
Gross Profit
-$647.00K
Operating Income
-$88.98M
EBITDA
-$88.34M
Operating Cash Flow
-$66.30M
Capital Expenditure
-$377.00K
Free Cash Flow
-$66.67M
Cash & ST Invst.
$235.88M
Total Debt
$8.68M
Sionna Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$154.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$1.60B
N/A
Market Cap/Employee
$38.95M
N/A
Employees
41
N/A
Net Income
-$26.78M
-62.5%
EBITDA
-$29.45M
-53.1%
Quarterly Fundamentals
Net Cash
$207.77M
-20.1%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$7.06M
-15.8%
Short Term Debt
$1.32M
+18.1%
Return on Assets
-28.05%
N/A
Return on Invested Capital
-33.50%
N/A
Free Cash Flow
-$21.84M
-33.4%
Operating Cash Flow
-$21.84M
-34.1%